According to IMARC Group’s latest report, titled “Gold Nanoparticles Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” Offers a comprehensive analysis of the industry, which comprises insights on gold nanoparticles market.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The global gold nanoparticles market reached a value of US$ 4.4 Billion in 2021. Gold nanoparticles, represented as AuNPs, have a diameter of 1 to 100 nanometers (nm). They are majorly used in biotechnological and biomedical sciences owing to their large surface area and inertness. Gold nanoparticles also have high electron stability, conductivity, and solubility. They are manufactured as nanocages, nanorods, nanospheres, nano shells, nano cubes, nanoclusters, etc., and are utilized in targeted drug administration. Gold nanoparticles also assist as optical imaging probes for the detection of biomarkers of various diseases and in imaging procedures, such as computed tomography (CT), positron emission tomography (PET), magnetic resonance imaging (MRI), and ultrasound scans. As a result, they find extensive applications across several sectors, including chemical, pharmaceutical, electronics, etc.
Request Free Sample report: https://www.imarcgroup.com/gold-nanoparticles-market/requestsample
Market Trends:
The escalating demand for these materials in the medical industry, especially in the dental sector, for target imaging in cancer therapy and dental fillings is among the primary factors driving the gold nanoparticles market. Besides this, the elevating demand for these substances to produce inks used in storage devices, hard disks, and microchips and in the manufacturing of photo-sensors and thin-film transistors is further augmenting the market growth. Apart from this, the food and beverage (F&B) industry utilizes colorimetric sensors produced using these particles as these sensors assist in detecting the freshness and health of food products. This, in turn, is also stimulating the global market. Moreover, the development of injectable plant plastids to enhance biosynthesis and the extensive research and development (R&D) activities are expected to bolster the gold nanoparticles market in the coming years. Looking forward, IMARC Group expects the market to reach US$ 8.9 Billion by 2027, exhibiting a CAGR of 12.2% during 2022-2027.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/gold-nanoparticles-market
List of Key Companies Covered in this Market Report:
- Agilent Technologies
- BBI Solutions
- Cline Scientific
- Cytodiagnostics
- Expedeon
- Goldsol
- Meliorum Technologies
- Merck Group
- Metalor Technologies International
- Nanocomposix
- NanoHybrids
- Nanopartz
- Sigma-Aldrich
- Solaris Nanosciences Corporation
- Tanaka Kikinzoku
The report has segmented the market on the basis of type, application, end use industry and geography.
Breakup by Type:
- Water Soluble
- Oil Soluble
- Others
Breakup by Application:
- Imaging
- Targeted Drug Delivery
- Sensors
- In Vitro Diagnostics
- Probes
- Catalysis
- Others
Breakup by End-Use Industry:
- Electronics
- Healthcare
- Chemicals
- Others
Breakup by Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
